Trimurthi Pharmaceuticals (India) Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Trimurthi Pharmaceuticals (India) Private Limited

Trimurthi Pharmaceuticals (India) Private Limited, a active private limited company, was established on 12 April 2012 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2012PTC080276. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

Formerly known as Skf Lifescience Private Limited. It upholds a compliant status. Its leadership includes Aditya Bhangadia (Director), Arvind Kumar Bhangadia (Whole-Time Director). Past directors included Pramod Jagannath Bhagdiya, Aditya Bhangadia, Arvind Kumar Bhangadia. It holds ₹1.66 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4-4-231/1/2/Abc,Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2012PTC080276

  • Registration Number

    080276

  • Incorporation Date

    12 April 2012

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.66 M
  • Revenue Growth **** 72.27%
  • Profit Growth **** -835.84%
  • Ebitda **** -1712.35%
  • Net Worth -45.39%
  • Total Assets **** 19.52%
Company report

Trimurthi Pharmaceuticals (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Trimurthi Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Trimurthi Pharmaceuticals (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Aditya Bhangadia Director 03 Sep 2016 Current
Arvind Kumar Bhangadia Whole-Time Director 01 Jun 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jun 2015 Past
Pramod Abcsdd Director 01 Oct 2020 Past
Pramod Abcsdd Director 01 Oct 2020 Past
Pramod Abcsdd Director 24 Jul 2013 Past
Pramod Abcsdd Director 03 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Trimurthi Pharmaceuticals (India).

Trimurthi Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.27% increase. The company also saw a substantial fall in profitability, with a 835.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45.39%.

Trimurthi Pharmaceuticals (India) revenue growth over time
Trimurthi Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 72.27%
*******
*******
*******
*******
Revenue from Operations
*******
 72.30%
*******
*******
*******
*******
Total Assets
*******
 19.52%
*******
*******
*******
*******
Profit or Loss
*******
 -835.84%
*******
*******
*******
*******
Net Worth
*******
 -45.39%
*******
*******
*******
*******
EBITDA
*******
 -1712.35%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Trimurthi Pharmaceuticals (India)?

In 2022, Trimurthi Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,656,496.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.17 Cr
Latest Charge Details
Date Lender Amount Status
16 Apr 2022 Hdfc Bank Limited ₹1.66 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Trimurthi Pharmaceuticals (India)?

Unlock and access historical data on people associated with Trimurthi Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Trimurthi Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trimurthi Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Trimurthi Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Trimurthi Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Trimurthi Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 1.66 M with Charge ID 100593093 was registered on 16 Apr 2022. was completed.

  • Director Appointment

    Progress on Aditya Bhangadia was appointed as a Director was appointed as a Director on 03 Sep 2016 & has been associated with this company since 9 years 4 months . was documented.

  • Director Appointment

    The activity Arvind Kumar Bhangadia was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jun 2015 & has been associated with this company since 10 years 8 months . was completed.

  • Company Incorporation

    Progress on Trimurthi Pharmaceuticals (India) Private Limited was registered on 12 Apr 2012 with Roc Hyderabad & aged 13 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Trimurthi Pharmaceuticals (India) Private Limited?

The CIN of Trimurthi Pharmaceuticals (India) Private Limited is U24232TG2012PTC080276.

Where is Trimurthi Pharmaceuticals (India) Private Limited headquartered?

Trimurthi Pharmaceuticals (India) Private Limited is headquartered at 4-4-231/1/2/Abc,Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095.

When was Trimurthi Pharmaceuticals (India) Private Limited incorporated?

Trimurthi Pharmaceuticals (India) Private Limited was incorporated on 12 April 2012.

Who are the current directors of Trimurthi Pharmaceuticals (India) Private Limited?

The current directors of Trimurthi Pharmaceuticals (India) Private Limited are

What is the primary industry of Trimurthi Pharmaceuticals (India) Private Limited?

The primary industry of Trimurthi Pharmaceuticals (India) Private Limited is Trade.

Is Trimurthi Pharmaceuticals (India) Private Limited a listed company?

Trimurthi Pharmaceuticals (India) Private Limited is unlisted.

What is the capital structure of Trimurthi Pharmaceuticals (India) Private Limited?

The authorized capital of Trimurthi Pharmaceuticals (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Trimurthi Pharmaceuticals (India) Private Limited?

The compliance status of Trimurthi Pharmaceuticals (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available